ReviewAntibody therapeutics2026

Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.

Junming Yie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.